Suche

Programmdetails

Postervorträge

Cardiovascular Inflammation

Donnerstag, 4. April | 09:30 - 11:00 Uhr | Posterbereich 9

Vorsitz/Chair: Michael Joner (München), Bernhard Schieffer (Marburg)

Agenda

(P487)
Nitroxolin is a novel inhibitor of NLRP3-dependent pyroptosis
C. Mäder (Leipzig)
(P488)
Antiplatelet and anticoagulant compound (APAC) restricts thromboinflammation to ameliorates myocardial ischemia reperfusion injury
A. Arif (Leipzig)
(P489)
Thrombin receptors as candidate therapeutic targets to prevent post-operative atrial fibrillation
I. Abu-Taha (Essen)
(P490)
Double-stranded RNA sensing links antiviral innate immunity with pulmonary endothelial barrier integrity
G. Ciliberti (Mannheim)
(P491)
Expression of human ACE2 in cardiomyocytes promotes COVID-19 and transcriptional cardiac remodeling and viral replication in lungs of K18-hACE2 transgenic mice
J. Duran (Heidelberg)
(P492)
ARDS disrupts cardiac macrophage subsets
J. Grune (Berlin)
(P493)
Atherosclerosis licenses for an exceeding immune response in COVID-19 disease
J. Leberzammer (Frankfurt am Main)
(P494)
Optimized assessement of infectious endocarditis with a novel wire-injury based murine model
B. C. Bartsch (Bonn)
Diese Seite teilen